Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

July 6, 2020 | Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Miguel A Hernán, Mayte Pérez-Olmeda, Jose L Sanmartín, Aurora Fernández-García, Israel Cruz, Nerea Fernández de Larrea, Marta Molina, Francisco Rodríguez-Cabera, Mariano Martín, Paloma Merino-Amador, Jose León Paniagua, Juan F Muñoz-Montalvo, Faustino Blanco, Raquel Yotti, on behalf of the ENE-COVID Study Group*
The COVID-19 resource centre, hosted by Elsevier, provides free information in English and Mandarin on the novel coronavirus. Elsevier grants permission to make all its COVID-19-related research available in PubMed Central and other public repositories, allowing unrestricted reuse and analysis with acknowledgment of the original source. A nationwide, population-based seroepidemiological study in Spain estimated the prevalence of SARS-CoV-2 infection at 5.0% (95% CI 4.7–5.4) by a point-of-care test and 4.6% (4.3–5.0) by an immunoassay. Seroprevalence varied geographically, with higher rates around Madrid and lower rates in coastal areas. The study found that around a third of seropositive individuals were asymptomatic, and most PCR-confirmed cases had detectable antibodies. These findings highlight the need to maintain public health measures to prevent a new epidemic wave.The COVID-19 resource centre, hosted by Elsevier, provides free information in English and Mandarin on the novel coronavirus. Elsevier grants permission to make all its COVID-19-related research available in PubMed Central and other public repositories, allowing unrestricted reuse and analysis with acknowledgment of the original source. A nationwide, population-based seroepidemiological study in Spain estimated the prevalence of SARS-CoV-2 infection at 5.0% (95% CI 4.7–5.4) by a point-of-care test and 4.6% (4.3–5.0) by an immunoassay. Seroprevalence varied geographically, with higher rates around Madrid and lower rates in coastal areas. The study found that around a third of seropositive individuals were asymptomatic, and most PCR-confirmed cases had detectable antibodies. These findings highlight the need to maintain public health measures to prevent a new epidemic wave.
Reach us at info@study.space
Understanding Prevalence of SARS-CoV-2 in Spain (ENE-COVID)%3A a nationwide%2C population-based seroepidemiological study